子宫动脉栓塞术治疗肌瘤性红细胞增多症综合征
本文报告一例68岁女性,有7年红细胞增多症病史,最初被认为继发于胃肠道间质瘤,但切除后仍持续。后续检查发现11.2 cm黏膜下子宫肌瘤,考虑肌瘤性红细胞增多症综合征。患者拒绝手术,接受反复放血维持血细胞比容低于45%,后于2017年7月接受子宫动脉栓塞术,随访17个月血细胞比容保持正常。结论认为子宫动脉栓塞术是肌瘤性红细胞增多症综合征的有效替代治疗方式。
要点
- 肌瘤性红细胞增多症综合征是子宫肌瘤相关的继发性红细胞增多症,增加血栓风险。
- 本例患者因拒绝手术而接受子宫动脉栓塞术,术后血细胞比容维持正常达17个月。
- 子宫动脉栓塞术可作为肌瘤性红细胞增多症综合征的有效替代治疗选择。
核心结论
- 子宫动脉栓塞术是肌瘤性红细胞增多症综合征的有效替代治疗方式。
研究设计与样本
- 个案报告,报告一例68岁女性患者。
主要发现
- 患者有7年红细胞增多症病史,最初认为继发于胃肠道间质瘤,但肿瘤切除后红细胞增多症仍持续。
- 后续检查发现11.2 cm黏膜下子宫肌瘤,考虑肌瘤性红细胞增多症综合征。
- 患者拒绝手术,持续接受反复放血以维持血细胞比容低于45%,直至咨询介入放射学专家。
- 患者于2017年7月接受子宫动脉栓塞术,术后17个月随访期间血细胞比容保持在正常范围内。
临床怎么用
- 作者结论认为子宫动脉栓塞术是肌瘤性红细胞增多症综合征的有效替代治疗方式。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Myomatous erythrocytosis syndrome, a form of secondary polycythemia associated with uterine leiomyomas, increases the risk of thrombosis and traditionally has been treated with hysterectomy. CASE: The patient is a 68-year-old woman with 7-year history of polycythemia initially thought to be secondary to a gastrointestinal stromal tumor that persisted after resection. A subsequent search for an alternative etiology led to the discovery of an 11.2-cm submucosal leiomyoma and likelihood of myomatous erythrocytosis syndrome. The patient declined surgical management and continued to undergo recurrent phlebotomy to maintain a hematocrit of less than 45% until consultation with an interventional radiology specialist. She underwent uterine artery embolization in July 2017, and her hematocrit has remained within normal limits through 17 months of follow-up. CONCLUSION: Uterine artery embolization is an effective alternative treatment modality for myomatous erythrocytosis syndrome.
引用
- Gordon B, Fischbeck T, Salamo R, et al. Treating Myomatous Erythrocytosis Syndrome With Uterine Artery Embolization. Obstet Gynecol. 2019. PMID: 31135745. doi:10.1097/AOG.0000000000003289
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。